BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4447784)

  • 1. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
    Lewkonia RM; Kerr EJ; Irvine WJ
    Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
    Günther J
    Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
    Rawlins GA; Wood JM; Bagshawe KD
    Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
    Rahi AH; Otiko G; Winder AF
    Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
    Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
    Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
    Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
    Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
    Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
    Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
    Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
    Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electrophoretic mobility test (EMT) and cancer diagnosis.
    Porzsolt F
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):183-7. PubMed ID: 746683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.